These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7504454)

  • 21. Evaluation of CD44 variant 6 expression and clinicopathological factors in pulmonary metastases from colon carcinoma.
    Indinnimeo M; Cicchini C; Giarnieri E; Stazi A; Mingazzini PL; Stipa V
    Oncol Rep; 2003; 10(6):1875-7. PubMed ID: 14534711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of variant CD44 in nasopharyngeal carcinoma is unrelated to expression of LMP-1.
    Brooks L; Niedobitek G; Agathanggelou A; Farrell PJ
    Am J Pathol; 1995 May; 146(5):1102-12. PubMed ID: 7538265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD44 splice variants: metastases meet lymphocytes.
    Herrlich P; Zöller M; Pals ST; Ponta H
    Immunol Today; 1993 Aug; 14(8):395-9. PubMed ID: 7691067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium.
    Dall P; Heider KH; Hekele A; von Minckwitz G; Kaufmann M; Ponta H; Herrlich P
    Cancer Res; 1994 Jul; 54(13):3337-41. PubMed ID: 7516819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
    Gross N; Beretta C; Peruisseau G; Jackson D; Simmons D; Beck D
    Cancer Res; 1994 Aug; 54(15):4238-42. PubMed ID: 7518353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are CD44 variant isoforms involved in human tumour progression?
    Günthert U; Stauder R; Mayer B; Terpe HJ; Finke L; Friedrichs K
    Cancer Surv; 1995; 24():19-42. PubMed ID: 7553660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of epitopes CD44v3 and CD44v6 in the invasive behavior of fibroblast-like synoviocytes derived from rheumatoid arthritic joints.
    Wibulswas A; Croft D; Pitsillides AA; Bacarese-Hamilton I; McIntyre P; Genot E; Kramer IM
    Arthritis Rheum; 2002 Aug; 46(8):2059-64. PubMed ID: 12209509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trans-acting factors regulate the expression of CD44 splice variants.
    Konig H; Moll J; Ponta H; Herrlich P
    EMBO J; 1996 Aug; 15(15):4030-9. PubMed ID: 8670907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD44 isoforms in metastatic cancer.
    Ponta H; Sleeman J; Dall P; Moll J; Sherman L; Herrlich P
    Invasion Metastasis; 1994-1995; 14(1-6):82-6. PubMed ID: 7544777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.
    Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Cosio S; Prontera C; Bianchi R; Genazzani AR
    Anticancer Res; 1997; 17(6D):4463-6. PubMed ID: 9494551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
    Abetamann V; Kern HF; Elsässer HP
    Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.
    Stickeler E; Runnebaum IB; Möbus VJ; Kieback DG; Kreienberg R
    Anticancer Res; 1997; 17(3C):1871-6. PubMed ID: 9216637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential.
    Lokeshwar BL; Lokeshwar VB; Block NL
    Anticancer Res; 1995; 15(4):1191-8. PubMed ID: 7544562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas.
    Satoh K; Shimosegawa T; Koizumi M; Toyota T
    Anticancer Res; 1997; 17(1A):215-9. PubMed ID: 9066654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas.
    Chuang CK; Liao SK
    Anticancer Res; 2003; 23(6C):4635-9. PubMed ID: 14981907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of CD44 metastatic variant mRNA in colorectal carcinomas and its role in tumor metastasis and invasion].
    Sugaya Y; Harigaya K
    Nihon Rinsho; 1995 Jul; 53(7):1699-703. PubMed ID: 7630010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma.
    Jalkanen S; Joensuu H; Söderström KO; Klemi P
    J Clin Invest; 1991 May; 87(5):1835-40. PubMed ID: 2022749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development.
    Horst E; Meijer CJ; Radaskiewicz T; van Dongen JJ; Pieters R; Figdor CG; Hooftman A; Pals ST
    Leukemia; 1990 May; 4(5):383-9. PubMed ID: 2201831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.
    Sinn HP; Heider KH; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H
    Breast Cancer Res Treat; 1995; 36(3):307-313. PubMed ID: 8573713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.